AR020681A1 - Composicion para el tratamiento de la enfermedad retinal degenerativa causada por herida luminica. - Google Patents
Composicion para el tratamiento de la enfermedad retinal degenerativa causada por herida luminica.Info
- Publication number
- AR020681A1 AR020681A1 ARP990104979A ARP990104979A AR020681A1 AR 020681 A1 AR020681 A1 AR 020681A1 AR P990104979 A ARP990104979 A AR P990104979A AR P990104979 A ARP990104979 A AR P990104979A AR 020681 A1 AR020681 A1 AR 020681A1
- Authority
- AR
- Argentina
- Prior art keywords
- treatment
- composition
- injury
- disease caused
- degenerative disease
- Prior art date
Links
- 208000027418 Wounds and injury Diseases 0.000 title abstract 3
- 230000006378 damage Effects 0.000 title abstract 3
- 208000014674 injury Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 230000002207 retinal effect Effects 0.000 title 1
- 230000007850 degeneration Effects 0.000 abstract 3
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 abstract 1
- 206010025421 Macule Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- QKTMWKGOONRWKC-UHFFFAOYSA-N calcium;1,2-dihydropyridine Chemical compound [Ca].C1NC=CC=C1 QKTMWKGOONRWKC-UHFFFAOYSA-N 0.000 abstract 1
- 210000002189 macula lutea Anatomy 0.000 abstract 1
- 229960000715 nimodipine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10297298P | 1998-10-02 | 1998-10-02 | |
| US11070098P | 1998-12-03 | 1998-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR020681A1 true AR020681A1 (es) | 2002-05-22 |
Family
ID=26799937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990104979A AR020681A1 (es) | 1998-10-02 | 1999-10-01 | Composicion para el tratamiento de la enfermedad retinal degenerativa causada por herida luminica. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6248759B1 (https=) |
| EP (1) | EP1117404A1 (https=) |
| JP (1) | JP2002526409A (https=) |
| AR (1) | AR020681A1 (https=) |
| AU (1) | AU5998399A (https=) |
| BR (1) | BR9914254A (https=) |
| CA (1) | CA2346086A1 (https=) |
| WO (1) | WO2000020002A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005204391A1 (en) * | 2004-01-14 | 2005-07-28 | Lavipharm Laboratories, Inc. | Transdermal delivery device for dihydropyridine type calcium antagonists containing at least one fatty acid |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2585574B1 (fr) * | 1985-07-31 | 1988-09-09 | Corbiere Jerome | Nouvelles compositions pharmaceutiques anti-glaucomateuses a base de 1,4-dihydropyridines et leur procede d'obtention |
| WO1990006123A1 (en) * | 1988-12-05 | 1990-06-14 | Houston Biotechnology Incorporated | Therapeutic use of calcium entry blockers in retinal or optic nerve dysfunction |
| FR2642307A1 (fr) * | 1989-01-27 | 1990-08-03 | Corbiere Jerome | Medicament pour le traitement des maladies degeneratives de la retine et notamment des maladies conditionnees genetiquement, et un procede pour leur obtention |
| JP3041923B2 (ja) * | 1990-06-27 | 2000-05-15 | 藤沢薬品工業株式会社 | ジヒドロピリジン化合物を含有する抗炎症および活性酸素産生抑制剤 |
| US5691360A (en) * | 1993-12-08 | 1997-11-25 | Alcon Laboratories, Inc. | Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| EP0911027A4 (en) | 1996-04-26 | 2000-11-29 | Fujisawa Pharmaceutical Co | THE DIHYDROPYRIDINE CONTAINS TO IMPROVE THE CIRCULATION OF THE EYE-SURROUNDING TISSUE |
| JPH1072347A (ja) | 1996-05-27 | 1998-03-17 | Otsuka Pharmaceut Co Ltd | 眼血管血流改善剤 |
-
1999
- 1999-09-29 EP EP99970023A patent/EP1117404A1/en not_active Withdrawn
- 1999-09-29 AU AU59983/99A patent/AU5998399A/en not_active Abandoned
- 1999-09-29 WO PCT/JP1999/005321 patent/WO2000020002A1/en not_active Ceased
- 1999-09-29 CA CA002346086A patent/CA2346086A1/en not_active Abandoned
- 1999-09-29 JP JP2000573361A patent/JP2002526409A/ja not_active Withdrawn
- 1999-09-29 BR BR9914254-6A patent/BR9914254A/pt not_active Application Discontinuation
- 1999-09-30 US US09/408,562 patent/US6248759B1/en not_active Expired - Fee Related
- 1999-10-01 AR ARP990104979A patent/AR020681A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000020002A1 (en) | 2000-04-13 |
| JP2002526409A (ja) | 2002-08-20 |
| BR9914254A (pt) | 2001-07-03 |
| EP1117404A1 (en) | 2001-07-25 |
| CA2346086A1 (en) | 2000-04-13 |
| AU5998399A (en) | 2000-04-26 |
| US6248759B1 (en) | 2001-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2156603T3 (es) | Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina. | |
| BR0206381A (pt) | Derivados do ácido fumárico como inibidor de nf-kappab | |
| BRPI0508540B8 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR9910066A (pt) | Composição farmacêutica fluida que permite a liberação controlada de pelo menos uma substância ativa, processo de fabricação de uma composição farmacêutica, e, utilização de uma composição | |
| BR0100558A (pt) | Composições e métodos para tratar a osteoporose | |
| DE69732170D1 (de) | Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan | |
| BR0211364A (pt) | Composição farmacêutica para tratamento de doenças associadas com redução na massa óssea compreendendo o agonista ep4 como componente ativo | |
| PT750618E (pt) | Derivados de oxazolidinona e composicoes farmaceuticas que os contem | |
| ATE452640T1 (de) | Mittel für erkrankungen assoziert mit knochensubstanzverlust | |
| MX2019010598A (es) | Composicion farmaceutica que comprende selexipag. | |
| DE602006017694D1 (de) | C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden | |
| CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
| ES2131373T3 (es) | Composicion oftalmica para prevenir o tratar el ojo seco o una enfermedad causada por el mismo, que comprende acido 12-sulfodeshidroabietico. | |
| BR0209327A (pt) | Composição para tratamento de constipação induzida por drogas | |
| AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| ECSP066608A (es) | Suspensiones acuosas de ciclesonide para nebulización | |
| AR012504A1 (es) | Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion. | |
| CO5611124A2 (es) | Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos | |
| BRPI0413013A (pt) | composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças | |
| DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| CY1110644T1 (el) | 5,6,7-τριυδροξυεπτανοϊκο οξυ και τα αναλογα για την θεραπεια οφθαλμικων ασθενειων που σχετιζονται με υπερεκφυτικες και αγγειογενεις αντιδρασεις | |
| BR9907715A (pt) | Composição oftálmica/método para tratamento de lesão córnea e/ou de estesia córnea deteriordada, sìndrome de olho seco, hipolarcrimação e uso de um inibidor de redutase de aldose | |
| BRPI0411702A (pt) | uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral | |
| BR0013313A (pt) | Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |